Innocare Optoelectronics Corp.
InnoCare Optoelectronics Corporation engages in the design, development, manufacture, and sale of X-ray flat panel detectors and sensors for healthcare, veterinary, security, and industrial applications in Taiwan and internationally. It offers thin film transistors and scintillators, and other medical products, as well as accessories, including power and ethernet cables, charger sets, and batteri… Read more
Innocare Optoelectronics Corp. (6861) - Net Assets
Latest net assets as of September 2025: NT$1.40 Billion TWD
Based on the latest financial reports, Innocare Optoelectronics Corp. (6861) has net assets worth NT$1.40 Billion TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$2.45 Billion) and total liabilities (NT$1.05 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$1.40 Billion |
| % of Total Assets | 57.16% |
| Annual Growth Rate | 36.57% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 21.67 |
Innocare Optoelectronics Corp. - Net Assets Trend (2020–2024)
This chart illustrates how Innocare Optoelectronics Corp.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Innocare Optoelectronics Corp. (2020–2024)
The table below shows the annual net assets of Innocare Optoelectronics Corp. from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$1.38 Billion | +7.67% |
| 2023-12-31 | NT$1.28 Billion | +57.32% |
| 2022-12-31 | NT$816.62 Million | +28.26% |
| 2021-12-31 | NT$636.68 Million | +60.14% |
| 2020-12-31 | NT$397.58 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Innocare Optoelectronics Corp.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 171.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$476.58 Million | 34.45% |
| Common Stock | NT$415.05 Million | 30.01% |
| Other Components | NT$491.60 Million | 35.54% |
| Total Equity | NT$1.38 Billion | 100.00% |
Innocare Optoelectronics Corp. Competitors by Market Cap
The table below lists competitors of Innocare Optoelectronics Corp. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Asia Pacific Satellite Inc
KQ:211270
|
$94.51 Million |
|
STEICO SE
XETRA:ST5
|
$94.51 Million |
|
OPTIMIZERx Corp
NASDAQ:OPRX
|
$94.52 Million |
|
Pasifik Donanım ve Yazılım Bilgi Tek As
IS:PATEK
|
$94.53 Million |
|
Jiangsu Huasheng Tianlong Photo
SHE:300029
|
$94.42 Million |
|
Slide Insurance Holdings, Inc. Common Stock
NASDAQ:SLDE
|
$94.42 Million |
|
Gorilla Gold Mines Ltd
AU:GG8
|
$94.34 Million |
|
Carbios SAS
PINK:COOSF
|
$94.31 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Innocare Optoelectronics Corp.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,284,749,000 to 1,383,227,000, a change of 98,478,000 (7.7%).
- Net income of 152,939,000 contributed positively to equity growth.
- Dividend payments of 44,294,000 reduced retained earnings.
- New share issuances of 18,117,000 increased equity.
- Other factors decreased equity by 28,284,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$152.94 Million | +11.06% |
| Dividends Paid | NT$44.29 Million | -3.2% |
| Share Issuances | NT$18.12 Million | +1.31% |
| Other Changes | NT$-28.28 Million | -2.04% |
| Total Change | NT$- | 7.67% |
Book Value vs Market Value Analysis
This analysis compares Innocare Optoelectronics Corp.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.82x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 12.56x to 4.82x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | NT$12.54 | NT$157.50 | x |
| 2021-12-31 | NT$17.62 | NT$157.50 | x |
| 2022-12-31 | NT$21.45 | NT$157.50 | x |
| 2023-12-31 | NT$31.28 | NT$157.50 | x |
| 2024-12-31 | NT$32.65 | NT$157.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Innocare Optoelectronics Corp. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.06%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.69%
- • Asset Turnover: 0.84x
- • Equity Multiplier: 1.71x
- Recent ROE (11.06%) is below the historical average (23.48%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 41.76% | 7.11% | 1.15x | 5.11x | NT$126.27 Million |
| 2021 | 31.18% | 10.23% | 1.14x | 2.68x | NT$134.85 Million |
| 2022 | 24.33% | 10.53% | 0.94x | 2.45x | NT$117.05 Million |
| 2023 | 9.08% | 6.35% | 0.81x | 1.77x | NT$-11.82 Million |
| 2024 | 11.06% | 7.69% | 0.84x | 1.71x | NT$14.62 Million |
Industry Comparison
This section compares Innocare Optoelectronics Corp.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,274,214,400
- Average return on equity (ROE) among peers: 6.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Innocare Optoelectronics Corp. (6861) | NT$1.40 Billion | 41.76% | 0.75x | $94.44 Million |
| Health & Life Co., Ltd. (1781) | $372.58 Million | -4.71% | 1.15x | $12.97 Million |
| Hi-Clearance (1788) | $3.00 Billion | 11.98% | 0.65x | $104.25 Million |
| Radiant Innovation (3373) | $865.89 Million | -3.30% | 0.08x | $18.65 Million |
| Wellell Inc (4106) | $1.31 Billion | 13.81% | 0.24x | $37.12 Million |
| Rossmax International Ltd (4121) | $1.33 Billion | 1.93% | 1.30x | $38.32 Million |
| United Orthopedic (4129) | $1.77 Billion | 7.55% | 0.46x | $300.33 Million |
| Dynamic Medical Technologies (4138) | $1.76 Billion | 11.67% | 0.71x | $39.41 Million |
| Ok Biotech Co Ltd (4155) | $1.30 Billion | 9.66% | 0.71x | $44.61 Million |
| Bioptik Technology (4161) | $717.83 Million | 6.76% | 1.11x | $30.42 Million |
| EPS Bio Technology Corp. (4183) | $309.15 Million | 10.25% | 0.77x | $4.27 Million |